-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Financial App News, Hehuang Pharmaceutical (00013.HK) announced that applications for regulatory registration of Warisha® (savolitinib) and Teresa® (osimertinib) combination therapy in Europe and Japan have been accepted.

Zhitongcaijing·11/02/2026 00:17:07
Listen to the news
Zhitong Financial App News, Hehuang Pharmaceutical (00013.HK) announced that applications for regulatory registration of Warisha® (savolitinib) and Teresa® (osimertinib) combination therapy in Europe and Japan have been accepted.